Experiences with real-world teclistamab administration in community and outpatient settings: a mixed-methods study of hematology providers
Outpatient teclistamab SUD has been successfully implemented in real-world practice for appropriately selected patients. This study provides insights into real-world outpatient SUD, including in community practices, to inform providers seeking to implement similar models to improve patient access while reducing cost and resource burden.
Authors
- Jane Jijun Liu
- Meaghan Roach (ORCID: https://orcid.org/0000-0002-1958-0020)
- Asya Varshavsky
- Muhamed Baljević (ORCID: https://orcid.org/0000-0002-0630-8458)
- Benjamin Avi Derman (ORCID: https://orcid.org/0000-0002-4070-1819)
- Lindsay Figg
- Dee Lin (ORCID: https://orcid.org/0000-0003-2565-7984)
- Justin LaPorte (ORCID: https://orcid.org/0000-0003-1811-1107)
- Kaley A. Pagan
- Niodita Gupta-Werner
- Agne Paner-Straseviciute
- Jason C. Fowler
- Salil Goorha
- Nicole Bariahtaris
- Amal Jamaleddine
- Richard Murphy
- Gilbert Ko
- Nicholas Bouchard
- Anand Tandra
Institutions
- Northside Hospital (US)
- Fox Chase Cancer Center (US)
- Cancer Institute (WIA) (IN)
- Norton University (KH)
- University of Chicago Medical Center (US)
- Baptist Cancer Center (US)
- European Society for Blood and Marrow Transplantation (NL)
- Hematology Oncology Associates of Central New York (US)
- The Korean Society of Blood and Marrow Transplantation (KR)
- Johnson & Johnson (Israel) (IL)
- Illinois CancerCare (US)
- National Institute Of Blood Disease and Bone Marrow Transplantation (PK)
- University of Louisville Physicians (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Current Medical Research and Opinion
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/03007995.2026.2626367
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00